Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance

J Immunol. 2005 Dec 1;175(11):7085-91. doi: 10.4049/jimmunol.175.11.7085.

Abstract

In recent years, several investigators have unraveled a previously unrecognized role for G-CSF in the regulation of T cell and dendritic cell functions. The experimental evidence in favor of G-CSF-mediated immune regulation includes the ability to switch T cell cytokine secretion profile to Th2 responses and the promotion of regulatory T cell and tolerogenic dendritic cell differentiation. Interestingly, G-CSF is beneficial in animals for the prevention and/or treatment of immune-mediated diseases, e.g., graft-vs-host disease, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, and diabetes, suggesting a potential role in human autoimmune diseases. This review summarizes the growing body of evidence that supports a critical role for G-CSF as a novel mediator of T cell tolerance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antigen Presentation / immunology
  • Autoimmune Diseases / drug therapy
  • Cytokines / immunology
  • Dendritic Cells / immunology
  • Granulocyte Colony-Stimulating Factor / immunology*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immune Tolerance / immunology*
  • Signal Transduction / immunology*
  • T-Lymphocytes / immunology*

Substances

  • Cytokines
  • Granulocyte Colony-Stimulating Factor